HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Xie, L. Articles by Gross, S. S. Search for Related Content PubMed PubMed Citation Articles by Xie, L. Articles by Gross, S. S. Social Bookmarking                      What's this?

Volume 272, Number 26, Issue of June 27, 1997 pp. 16624-16630
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Argininosuccinate Synthetase Overexpression in Vascular Smooth Muscle Cells Potentiates Immunostimulant-induced NO Production

(Received for publication, December 31, 1996, and in revised form, April 21, 1997)

Linjun Xie and Steven S. Gross ^§

From the  Department of Pharmacology and ^§ Program in Biochemistry and Structural Biology, Cornell University Medical College, New York, New York 10021

Immunostimulants trigger vascular smooth muscle cells (VSMC) to express both the inducible isoform of NO synthase (iNOS) and argininosuccinate synthetase (AS). With constitutively expressed argininosuccinate lyase (AL), AS confers cells with an Arg/Cit cycle that can sustain NO production via continuous regeneration of the NOS substrate, L-arginine (Arg), from the NOS coproduct, L-citrulline (Cit). To assess whether NO synthesis can be rate-limited by Arg recycling, we tested whether AS-overexpressing cells have an enhanced capacity for immununostimulant-induced NO synthesis. Rat VSMC were stably transfected with human AS cDNA in a eukaryotic cell expression vector, driven by a strong viral promoter. AS activity in transfected VSMC exceeded that induced in untransfected cells treated for 24 h with a combination of bacterial lipopolysaccharide and interferon- (LPS/IFN). AS activity was predominantly associated with membranes but was also found in cytosol. Recombinant AS was purified from cytosol and possessed a specific activity exceeding that reported for native AS. Western blotting verified the basal expression of AS antigen in membranes from untreated AS-transfected VSMC and from untransfected VSMC after 24 h exposure to LPS/IFN. Epifluorescence histochemistry revealed a punctate distribution of AS antigen in transfected cells, consistent with a predominant membrane localization. Remarkably, on a per cell basis, LPS/IFN-induced NO production was 3-4-fold greater in AS-transfected cells than untransfected VSMC. In untransfected VSMC, maximal NO production during 48 h required millimolar Arg; notably, Cit was needed at 3-fold higher concentrations than Arg for a comparable NO synthesis rate. In contrast, AS-transfected VSMC utilized Arg and Cit equi-effectively and at much lower concentrations; 100 µM of either precursor supported a maximal rate of NO synthesis for 48 h. The enhanced ability of AS-transfected cells to produce NO, compared with untransfected cells, could not be ascribed to differences in iNOS protein content or LPS/IFN potency for immunoactivation. We conclude that transfection with AS provides a continuous flux of Arg which drives NO synthesis in immunoactivated VSMC. Arg regeneration by AS is rate-limiting to NO synthesis and apparently provides iNOS with a preferred cellular source of Arg. In accord with the reported "channeling" of substrates by urea cycle enzymes, we hypothesize that the Arg/Cit cycle sequesters a discrete pool of recyclable substrate that sustains high-output NO synthesis.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. R. Guerreiro, C. Lameu, E. F. Oliveira, C. F. Klitzke, R. L. Melo, E. Linares, O. Augusto, J. W. Fox, I. Lebrun, S. M. T. Serrano, et al. Argininosuccinate Synthetase Is a Functional Target for a Snake Venom Anti-hypertensive Peptide: ROLE IN ARGININE AND NITRIC OXIDE PRODUCTION J. Biol. Chem., July 24, 2009; 284(30): 20022 - 20033. [Abstract] [Full Text] [PDF]

				Y. Zhao, J. Zhang, H. Li, Y. Li, J. Ren, M. Luo, and X. Zheng An NADPH Sensor Protein (HSCARG) Down-regulates Nitric Oxide Synthesis by Association with Argininosuccinate Synthetase and Is Essential for Epithelial Cell Viability J. Biol. Chem., April 18, 2008; 283(16): 11004 - 11013. [Abstract] [Full Text] [PDF]

				B. L. Goodwin, L. C. Pendleton, M. M. Levy, L. P. Solomonson, and D. C. Eichler Tumor necrosis factor-{alpha} reduces argininosuccinate synthase expression and nitric oxide production in aortic endothelial cells Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1115 - H1121. [Abstract] [Full Text] [PDF]

				M. Satoh, T. Iwahori, N. Sugawara, and M. Yamazaki Liver argininosuccinate synthase binds to bacterial lipopolysaccharides and lipid A and inactivates their biological activities Innate Immunity, February 1, 2006; 12(1): 21 - 38. [Abstract] [PDF]

				S. M Morris Jr Arginine: beyond protein Am. J. Clinical Nutrition, February 1, 2006; 83(2): 508S - 512S. [Abstract] [Full Text] [PDF]

				S. M Morris JR Arginine metabolism in vascular biology and disease Vascular Medicine, July 1, 2005; 10(1_suppl): S83 - S87. [Abstract] [PDF]

				L. C. Pendleton, B. L. Goodwin, L. P. Solomonson, and D. C. Eichler Regulation of Endothelial Argininosuccinate Synthase Expression and NO Production by an Upstream Open Reading Frame J. Biol. Chem., June 24, 2005; 280(25): 24252 - 24260. [Abstract] [Full Text] [PDF]

				S. M Morris Jr Arginine metabolism in vascular biology and disease Vascular Medicine, May 1, 2005; 10(2_suppl): S83 - S87. [Abstract] [PDF]

				G. Hao, L. Xie, and S. S. Gross Argininosuccinate Synthetase is Reversibly Inactivated by S-Nitrosylation in Vitro and in Vivo J. Biol. Chem., August 27, 2004; 279(35): 36192 - 36200. [Abstract] [Full Text] [PDF]

				B. L. Goodwin, L. P. Solomonson, and D. C. Eichler Argininosuccinate Synthase Expression Is Required to Maintain Nitric Oxide Production and Cell Viability in Aortic Endothelial Cells J. Biol. Chem., April 30, 2004; 279(18): 18353 - 18360. [Abstract] [Full Text] [PDF]

				L. C. Pendleton, B. L. Goodwin, B. R. Flam, L. P. Solomonson, and D. C. Eichler Endothelial Argininosuccinate Synthase mRNA 5'-Untranslated Region Diversity. INFRASTRUCTURE FOR TISSUE-SPECIFIC EXPRESSION J. Biol. Chem., July 5, 2002; 277(28): 25363 - 25369. [Abstract] [Full Text] [PDF]

				C. T. Lemke and P. L. Howell Substrate Induced Conformational Changes in Argininosuccinate Synthetase J. Biol. Chem., April 5, 2002; 277(15): 13074 - 13081. [Abstract] [Full Text] [PDF]